Theleme Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,737,000
Closed -$92.1M 12
2023
Q1
$92.1M Sell
1,737,000
-1,203,000
-41% -$59M 3.96% 8
2022
Q4
$124M Hold
2,940,000
4.66% 6
2022
Q3
$108M Sell
2,940,000
-1,690,000
-37% -$75.2M 5.25% 6
2022
Q2
$197M Hold
4,630,000
7.91% 3
2022
Q1
$249M Buy
4,630,000
+2,480,000
+115% +$144M 7.95% 4
2021
Q4
$155M Buy
+2,150,000
New +$135M 2.58% 7

Other funds holding LRCX

Theleme Partners's LRCX Position: Q2 2023 in Review

Theleme Partners sold out of Lam Research (LRCX) in Q2 2023, closing a stake of 1,737,000 shares — an estimated $92.1M sold.

Theleme Partners first reported a position in LRCX in Q4 2021 and held it in 6 quarters. The position peaked at $249M in Q1 2022. 1,433 funds tracked by Wall St. Rank hold LRCX as of Q2 2023.

  • Theleme Partners reported no remaining Lam Research position as of Q2 2023 after selling out during the quarter.
  • Theleme Partners sold 1,737,000 Lam Research shares in Q2 2023, an estimated $92.1M.
  • Theleme Partners first reported a position in Lam Research in Q4 2021 and held it in 6 quarters.
  • Theleme Partners's Lam Research position peaked at $249M in Q1 2022.
  • 1,433 funds tracked by Wall St. Rank held Lam Research as of Q2 2023.

Based on Theleme Partners's 13F filing for Q2 2023, filed 14 Aug 2023.